Phoevos Hughes is a clinical operations executive with a background in law, committed to advancing therapeutic solutions for rare and underserved diseases. With a career spanning over a decade, he has consistently demonstrated excellence in strategic planning, cross-functional management, and the execution of clinical research programs. Phoevos’ unique blend of scientific, regulatory, and legal knowledge positions him as a dynamic leader in the biotechnology and pharmaceutical sectors.
As a clinical operations executive, Phoevos has overseen clinical programs and strategic study planning across the several companies. He also has extensive experience building quality management systems for clinical-stage companies, ensuring compliance and operational excellence.
Phoevos also brings significant regulatory experience that complements his leadership in clinical operations. Over the course of his career, he has overseen regulatory strategy and execution across all phases of development, from early proof-of-concept through commercialization. His experience includes leading global regulatory submissions (INDs, CTAs, MAAs), managing interactions with health authorities such as the FDA, EMA, and TGA, and ensuring inspection readiness across cross-functional teams. With a background in law, Phoevos is adept at navigating complex regulatory frameworks and contributes meaningfully to compliance, risk mitigation, and strategic decision-making. He has also played a central role in implementing regulatory strategies for rare disease and pediatric programs, where early engagement with regulators and innovative approaches are often key to success.